CLINICAL_TRIALS
trial_result
· 2009-08-12
Clinical Trial Update: Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Summary
Phase 3 safety and quality-of-life results for a dexlansoprazole modified-release formulation in gastroesophageal reflux disease have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-08-12